Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tirzepatide for the Treatment of Alcohol Use Disorder: A Pilot Randomized Controlled Trial

NCT06727331 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT06727331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06727331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tirzepatide for the Treatment of Alcohol Use Disorder: A Pilot Randomized Controlled Trial
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
September 15, 2025
Completion date
July 1, 2027
Enrollment
20 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol use disorder (aud)